Susan Bobulsky

Chief Commercial Officer, MRD · 2 filings · Latest: Mar 11, 2026

Adaptive Biotechnologies Corp

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ADPT	BOBULSKY SUSAN	—	Mar 11, 2026	Proposed Sale	$14.52	41,338	$600.2K	—	Mar 17 1:05 AM
ADPT	Susan Bobulsky	Chief Commercial Officer, MRD	Mar 11, 2026	Sale	$13.17	41,338	$544.4K	427,775	Mar 14 12:59 AM